E

Eloxx Pharmaceuticals

20 employees

Eloxx Pharmaceuticals is a clinical-stage biopharmaceutical company developing novel RNA-modulating drug candidates.

Basic info

Industry

biotechnology research

Sectors

Life Sciences
Biotechnology
Health Care
Biotech
Genetics
Healthcare
Rare Diseases
Drug Development
Pharmaceuticals

Date founded

2013

Funding rounds raised

Total raised

$30M

from 12 investors over 12 rounds

E

Eloxx Pharmaceuticals raised $30M on October 5, 2021

Investors: Hercules Capital, Inc.

E

Eloxx Pharmaceuticals raised $2.3M on August 1, 2019

Investors: Cybele Holdings

E

Eloxx Pharmaceuticals raised $8M on August 2, 2017

Investors: DSC Investment, Korea Investment Partners, Pontifax Venture Capital, OPKO Health, Inc., Quark Venture, LSP (Life Sciences Partners) and Catalyst Venture Partners

E

Eloxx Pharmaceuticals raised $30M on June 9, 2017

Investors: Catalyst Investments, Pontifax Venture Capital and Quark Venture

FAQ